DCM
EWTX icon

Driehaus Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Driehaus Capital Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192M Buy
4,728,623
+250,681
+6% +$8.64M 1.11% 12
2026
Q1 		$141M Buy
4,477,942
+286,749
+7% +$8.27M 1.04% 12
2025
Q4 		$104M Buy
4,191,193
+1,962,908
+88% +$39.4M 0.71% 32
2025
Q3 		$36.1M Buy
2,228,285
+126,504
+6% +$1.79M 0.26% 131
2025
Q2 		$27.6M Buy
2,101,781
+726,039
+53% +$10.5M 0.22% 145
2025
Q1 		$30.3M Sell
1,375,742
-118,049
-8% -$3.1M 0.29% 110
2024
Q4 		$39.9M Sell
1,493,791
-459,633
-24% -$14.6M 0.33% 101
2024
Q3 		$52.1M Buy
1,953,424
+693,032
+55% +$13.8M 0.45% 70
2024
Q2 		$22.7M Sell
1,260,392
-7,427
-0.6% -$130K 0.22% 128
2024
Q1 		$23.1M Buy
1,267,819
+872,750
+221% +$13.9M 0.23% 131
2023
Q4 		$4.32M Buy
+395,069
New +$2.77M 0.05% 274

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Driehaus Capital Management's EWTX Position: Q2 2026 in Review

Driehaus Capital Management increased its Edgewise Therapeutics (EWTX) stake by 5.6% in Q2 2026, buying an estimated $8.64M and bringing the position to 4,728,623 shares worth $192M. The position accounts for 1.11% of the portfolio, ranked #12.

Driehaus Capital Management first reported a position in EWTX in Q4 2023 and has held it in 11 quarters since. 227 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Driehaus Capital Management held 4,728,623 shares of Edgewise Therapeutics worth $192M as of Q2 2026.
  • Driehaus Capital Management bought 250,681 Edgewise Therapeutics shares in Q2 2026, an estimated $8.64M.
  • Edgewise Therapeutics made up 1.11% of Driehaus Capital Management's portfolio in Q2 2026, its #12 holding.
  • Driehaus Capital Management first reported a position in Edgewise Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 227 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.